Nicolette Sherman
Chairman at Deirdres House
Net worth: 397 035 $ as of 2024-04-29
Profile
Nicolette D.
Sherman's current job is Chairman at Deirdres House.
Ms. Sherman's former jobs include being the VP-North America Human Resources Operations at Sanofi Corp.
from 2008 to 2020, the Chief Human Resources Officer at Oyster Point Pharma, Inc. from 2020 to 2021, and the Chief Human Resources Officer at Certara, Inc. from 2021 to 2024.
Ms. Sherman's education history includes a graduate degree from Rutgers State University of New Jersey, an undergraduate degree from Lehigh University, and a graduate degree from the University of Delaware.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
CERTARA, INC.
0.02% | 2024-03-31 | 24,358 ( 0.02% ) | 397 035 $ | 2024-04-29 |
Nicolette Sherman active positions
| Companies | Position | Start |
|---|---|---|
| Deirdres House | Chairman | - |
Former positions of Nicolette Sherman
| Companies | Position | End |
|---|---|---|
| CERTARA, INC. | Human Resources Officer | 2024-05-20 |
| OYSR POIN | Human Resources Officer | 2021-06-30 |
| Sanofi Corp. | Corporate Officer/Principal | 2020-03-31 |
Training of Nicolette Sherman
| Rutgers State University of New Jersey | Graduate Degree |
| Lehigh University | Undergraduate Degree |
| University of Delaware | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| CERTARA, INC. | Technology Services |
| Private companies | 3 |
|---|---|
| Sanofi Corp. | |
Oyster Point Pharma, Inc.
 Oyster Point Pharma, Inc. Pharmaceuticals: MajorHealth Technology Oyster Point Pharma, Inc. engages in the development and commercialization of pharmaceutical therapies to treat ocular surface diseases. Its product candidate, OC-01, is a nicotinic acetylcholine receptor agonist, which is being developed as a nasal spray to treat the signs and symptoms of dry eye disease. The company was founded by Michael and is Ackermann in June 30, 2015 headquartered in Princeton, NJ. | Health Technology |
| Deirdres House |
- Stock Market
- Insiders
- Nicolette Sherman
